Principal Financial Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,146
| Closed | -$497K | – | 2440 |
|
|
2024
Q2 | $497K | Sell |
12,146
-15,085
| -55% | -$617K | ﹤0.01% | 1961 |
|
|
2024
Q1 | $1.15M | Buy |
27,231
+114
| +0.4% | +$4.82K | ﹤0.01% | 1850 |
|
|
2023
Q4 | $1.15M | Buy |
27,117
+430
| +2% | +$18.2K | ﹤0.01% | 1824 |
|
|
2023
Q3 | $583K | Buy |
26,687
+115
| +0.4% | +$2.51K | ﹤0.01% | 1918 |
|
|
2023
Q2 | $845K | Sell |
26,572
-1,607
| -6% | -$51.1K | ﹤0.01% | 1865 |
|
|
2023
Q1 | $687K | Sell |
28,179
-1,714
| -6% | -$41.8K | ﹤0.01% | 1910 |
|
|
2022
Q4 | $943K | Buy |
29,893
+4,597
| +18% | +$145K | ﹤0.01% | 1865 |
|
|
2022
Q3 | $715K | Sell |
25,296
-13
| -0.1% | -$367 | ﹤0.01% | 1894 |
|
|
2022
Q2 | $669K | Buy |
25,309
+1,075
| +4% | +$28.4K | ﹤0.01% | 1997 |
|
|
2022
Q1 | $849K | Sell |
24,234
-92
| -0.4% | -$3.22K | ﹤0.01% | 2005 |
|
|
2021
Q4 | $788K | Buy |
24,326
+15,916
| +189% | +$516K | ﹤0.01% | 2033 |
|
|
2021
Q3 | $248K | Buy |
+8,410
| New | +$248K | ﹤0.01% | 2369 |
|